Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Express Scripts
Baxter
Dow
Covington
Boehringer Ingelheim
Chinese Patent Office
Federal Trade Commission
US Department of Justice

Generated: April 24, 2018

DrugPatentWatch Database Preview

Ethacrynate sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ethacrynate sodium and what is the scope of ethacrynate sodium patent protection?

Ethacrynate sodium
is the generic ingredient in two branded drugs marketed by Aton, Mylan Institutional, Par Sterile Products, and Zydus Pharms Usa Inc, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for ethacrynate sodium. Six suppliers are listed for this compound.
Pharmacology for ethacrynate sodium
Synonyms for ethacrynate sodium
58-54-8 (Parent)
6500-81-8
Acetic acid, (2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy)-, sodium salt
AN-20071
C13H11Cl2O4.Na
CHEMBL1200487
D04079
D0W5UV
DTXSID10215320
Edecrin Sodium
Ethacrynate sodium (USP)
Ethacrynate sodium [USAN:USP]
Ethacrynate Sodium [USAN]
Ethacrynic acid sodium
K41MYV7MPM
LS-176418
OR067687
SCHEMBL42210
Sodium (2,3-dichloro-4-(2-methylenebutyryl)phenoxy)acetate
sodium 2-[2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetate
SODIUM 2-[2,3-DICHLORO-4-(2-METHYLIDENEBUTANOYL)PHENOXY]ACETATE
Sodium edecrin
Sodium ethacrynate
UNII-K41MYV7MPM

US Patents and Regulatory Information for ethacrynate sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aton EDECRIN ethacrynate sodium INJECTABLE;INJECTION 016093-001 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Par Sterile Products ETHACRYNATE SODIUM ethacrynate sodium INJECTABLE;INJECTION 205473-001 Jul 29, 2015 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Zydus Pharms Usa Inc ETHACRYNATE SODIUM ethacrynate sodium INJECTABLE;INJECTION 207758-001 Nov 17, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Institutional ETHACRYNATE SODIUM ethacrynate sodium INJECTABLE;INJECTION 204634-001 Aug 23, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Dow
Mallinckrodt
Teva
Baxter
McKinsey
Deloitte
Citi
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.